This week on MIP: Huawei-Ericsson deal, senior lawyer reveals Hong Kong SAR move
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

This week on MIP: Huawei-Ericsson deal, senior lawyer reveals Hong Kong SAR move

Ericsson.jpeg

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Breaking: Huawei and Ericsson strike 5G cross-licence

Huawei and Ericsson have agreed a long-term patent cross-licensing deal, the companies announced today, August 25.

The licence, finalised earlier this month, covers patents essential to a wide range of standards including 3GPP, ITU, IEEE, and IETF for 3G, 4G, and 5G cellular technologies.

Click here to read the full story.

Exclusive: Ex-Rouse disputes head to build IP practice at new firm

Rouse’s former global dispute resolution head, who quit the firm to run his own practice last year, is to join Tanner De Witt in Hong Kong SAR, Managing IP revealed.

Douglas Clark will formally start on September 1 and will be tasked with building the independent law firm’s intellectual property and international arbitration practices.

Click here to read the full story.

G20 urges ‘voluntary’ tech transfer amid IP row at WHO

G20 health ministers have hailed the importance of tech transfer and knowledge sharing to prevent future pandemics, but only on “voluntary and mutually agreed terms”.

An outcome statement, published after a two-day meeting of health ministers in Gujarat on Saturday, August 18, highlighted the need to improve access to vaccines, diagnostics, and therapies in developing countries.

Click here to read the full story.

Alexion and Samsung Bioepis settle German biosimilar lawsuit

Samsung Bioepis will continue to sell its biosimilar of a rare blood disorder drug in Germany after settling an orphan drug exclusivity lawsuit with Alexion.

Alexion, owned by AstraZeneca, sued Samsung Bioepis at the Munich Regional Court over the launch of a biosimilar of Soliris (eculizumab).

Click here to read the full story.

No copyright for AI-generated art, US judge rules

Artificial intelligence-generated works are not eligible for copyright protection, a US federal court ruled on Friday, August 18.

Computer scientist Stephen Thaler was appealing against the US Copyright Office’s refusal to register an image created by one of his inventions, an AI tool called the Creativity Machine.

Click here to read the full story.

Other articles published by Managing IP this week include:

Weekly take: What happened to the metaverse?

Why one letter could help Moderna avoid TM rejection

How firms can help medical device in-house with patent struggles

Carmakers have ‘no choice’ but to pay Avanci 5G rates: sources

Australian IP owners expected to ‘heavily resist’ Google’s AI proposal

India Google Ads ruling could fuel actions against intermediaries

How US litigators can minimise patent damages

Elsewhere in IP

Off-court drama

The New York Knicks has sued National Basketball Association rival the Toronto Raptors for the misappropriation of its trade secrets, including scouting reports.

Ikechukwu “Ike” Azotam, a former basketball player, worked for the Knicks from 2020 until this summer when he joined the Raptors.

Azotam allegedly sent thousands of confidential video files to the Raptors, a complaint filed at the US District Court for the Southern District of New York alleged.

Broadcast news

TV receiver maker Atlanta DTH (ADTH) has joined Avanci Broadcast as a licensee, it was confirmed on Wednesday, August 23.

Patent pool operator Avanci launched the pool in March this year to license patents essential to the Advanced Television Systems Committee 3.0 standard.

Avanci Broadcast currently includes 11 licensors, including LG, Sharp, Panasonic, and Samsung. ADTH is the pool’s sixth licensee.

Key UPC hearings

The Unified Patent Court has scheduled two preliminary injunction hearings between 10x Genomics and Nanostring for September.

The hearings will be the among first the UPC has heard on the merits of a case since the court opened on June 1.

The first hearing will take place on September 5, potentially spilling over until the next day, while the second will follow on September 19.

10x is seeking an injunction to prevent alleged patent infringement by Nanosting in a dispute over diagnostic devices.

The Munich local division will hear the cases.

Series trademarks

The UKIPO launched a consultation on digital services and the potential abolition of series trademarks on Tuesday, August 22.

Proposed changes would also allow the public to view documents relating to trademark and design applications online.

The UKIPO is also seeking views on how to enable more mediation as part of its tribunal service.

The consultation will close on October 31.

Google’s PTAB plea

Google general counsel Halimah DeLaine Prado told the USPTO that proposed changes to the Patent Trial and Appeal Board (PTAB) would allow artificial intelligence patents to “block and bottleneck innovation for years,” Reuters revealed yesterday, August 24.

The USPTO said in April that it was considering changes to the PTAB's rules of practice that would make it harder to challenge patents via inter partes review.

That's it for today, see you again next week.

more from across site and ros bottom lb

More from across our site

The full list of finalists has been revealed and the winners will be presented on June 20 at the Metropolitan Club in New York
A team of IP and media law specialists has joined from SK Schwarz alongside a former counsel at Sky
The Irish government has delayed a planned referendum on whether Ireland should join the Unified Patent Court, prompting concern about when a vote may take place
With more than 250 winners recognised during the ceremony, there are many reasons to be positive about the health of the IP industry in EMEA
Practitioners say the USPTO’s latest guidance has some helpful clarifications and is a good reminder of the importance of checking AI outputs
Susanne Schmidt discusses why trademarks are more than 'just a name' and why she would choose green farming as an alternative career
The former head of life sciences at Kramer Levin has joined Orrick, a firm that hopes to grow in the sector
Lionel Martin of August Debouzy and Kristof Neefs at Inteo share how they prevailed in a UPC Court of Appeal case surrounding access to documents
Counsel say ‘strange’ results have increased their reliance on subscription-based search platforms, but costs are not being shifted onto clients yet
The firm was among multiple winners at a record-breaking 2024 ceremony held in London on April 11
Gift this article